FCA
REGN icon

FinTrust Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

FinTrust Capital Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.17M Sell
1,950
-34
-2% -$37.8K 0.37% 57
2024
Q2 		$2.09M Sell
1,984
-39
-2% -$37.8K 0.38% 55
2024
Q1 		$1.95M Sell
2,023
-63
-3% -$59.9K 0.38% 55
2023
Q4 		$1.83M Buy
2,086
+149
+8% +$123K 0.37% 55
2023
Q3 		$1.59M Sell
1,937
-82
-4% -$64.4K 0.35% 58
2023
Q2 		$1.45M Buy
2,019
+250
+14% +$193K 0.35% 72
2023
Q1 		$1.33M Hold
1,769
– – 0.32% 75
2022
Q4 		$1.28M Sell
1,769
-72
-4% -$53.1K 0.31% 78
2022
Q3 		$1.31M Buy
1,841
+48
+3% +$30.2K 0.34% 72
2022
Q2 		$1.05M Sell
1,793
-218
-11% -$142K 0.26% 89
2022
Q1 		$1.41M Buy
2,011
+1,393
+225% +$881K 0.32% 72
2021
Q4 		$389K Sell
618
-481
-44% -$296K 0.09% 193
2021
Q3 		$665K Buy
1,099
+824
+300% +$512K 0.18% 116
2021
Q2 		$154K Buy
275
+38
+16% +$19.3K 0.04% 330
2021
Q1 		$112K Buy
237
+162
+216% +$78.9K 0.03% 388
2020
Q4 		$36K Buy
+75
New +$40.5K 0.01% 547
2019
Q2 		– Sell
-32
Closed -$13K – 1217
2019
Q1 		$13K Hold
32
– – 0.01% 712
2018
Q4 		$12K Buy
+32
New +$11.7K 0.01% 732

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

FinTrust Capital Advisors's REGN Position: Q3 2024 in Review

FinTrust Capital Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 1.7% in Q3 2024, selling an estimated $37.8K and leaving 1,950 shares worth $2.17M. The position accounts for 0.37% of the portfolio, ranked #57.

FinTrust Capital Advisors first reported a position in REGN in Q4 2018 and has held it in 18 quarters since. 1,391 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

  • FinTrust Capital Advisors held 1,950 shares of Regeneron Pharmaceuticals worth $2.17M as of Q3 2024.
  • FinTrust Capital Advisors sold 34 Regeneron Pharmaceuticals shares in Q3 2024, an estimated $37.8K.
  • Regeneron Pharmaceuticals made up 0.37% of FinTrust Capital Advisors's portfolio in Q3 2024, its #57 holding.
  • FinTrust Capital Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2018 and has held it in 18 quarters since.
  • 1,391 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.